drugset / Trial / NCT07309471

Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD

NCT07309471 ↗

RandomizedCrossoverQuadruple-blindOther

Summary

This study investigates DDH-LSD, a novel LSD-like compound expected to have a shorter duration of action than LSD. In healthy volunteers, pharmacokinetics, safety, and subjective effects, will be assessed and compare with LSD in a controlled cross-over study.

Timeline

Start
2026-03-06
Primary completion
2028-07
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Subject DDH-LSD Other / unclassified — Oral
Comparator LSD Other / unclassified 0.1 mg Oral

Indications

No indication recorded.